Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Location status: Recruiting
Location contact
Aaron W Aday, MD, MSc
SUB_INVESTIGATOR
Amanda M Morrison, MD
CONTACT
Amanda M Morrison, MD
PRINCIPAL_INVESTIGATOR
CONTACT
NCT Number: NCT07529691
Fibromuscular dysplasia (FMD) is a disease of the arteries that is not due to plaque build-up or inflammation. While some patients with FMD are health, some may experience heart attacks, strokes, aneurysms or blood vessel dissection/tearing which can be life-threatening. It predominantly impacts women and younger patients. As a result of this diagnosis, many patients are counseled to restrict or avoid certain physical activities out of concern for provoking or worsening vascular complications. There are no guidelines or consensus recommendations regarding appropriate physical activity for patients with FMD. The lack of consensus may lead to confusion for patients and may negatively impact their quality of life. This study will conduct a large, national survey of patients with FMD to assess the type of physical activity restrictions and impact on quality of life and emotional well-being.
Interested in participating?
Request Info18 year–100 year
All sexes
Observational
Nashville, Tennessee, 37232, United States
Location status: Recruiting
Aaron W Aday, MD, MSc
SUB_INVESTIGATOR
Amanda M Morrison, MD
CONTACT
Amanda M Morrison, MD
PRINCIPAL_INVESTIGATOR
CONTACT
Fibromuscular dysplasia (FMD) is a non-atherosclerotic, non-inflammatory disease of medium-sized arteries characterized by intimal and medial hyperplasia. The exact prevalence of FMD is unknown, but it predominantly impacts women and middle-age patients, with a mean age of 52 at the time of diagnosis. The manifestations of FMD are variable and may include spontaneous coronary artery dissection (SCAD) as well as extra-coronary vascular abnormalities (EVAs), such as peripheral artery aneurysms or dissections. Many patients are counseled to restrict or avoid certain physical activities out of concern for provoking or worsening vascular complications.3,4 However, there are no guidelines or consensus recommendations regarding appropriate physical activity for patients with FMD in the available 2018 American Heart Association (AHA) Scientific statement or the 2019 first international consensus document on FMD. Recommendations are formed based on expert opinion, and may vary based on a variety of factors including severity of disease, treating institution, or sex. The lack of consensus may lead to confusion for patients and may negatively impact their quality of life. This survey will be delivered electronically via RedCap to participants who self-identify as having a diagnosis of fibromuscular dysplasia. It will be the first to identify the breadth and content, as well as the impact, of physical activity recommendations provided by healthcare personnel to patients with FMD. Data gathered from this study will encourage the creation of an expert consensus document on recommendations for physical activity by FMD phenotype, which will have implications for patient education and empowerment for those living with FMD. This may also lead to areas of future intervention to mitigate adverse quality of life if identified.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline
Prevalence and type of clinician-recommended physical activity restrictions among patients diagnosed with fibromuscular dysplasia (FMD), including aerobic, resistance, and activity-specific limitations.
Time frame: Baseline
Change in physical activity behavior following FMD diagnosis based on patient self-report.
Time frame: Baseline
Self-reported anxiety or depression to physical activity recommendations and/or disease-related limitations.
Time frame: Baseline
Self-reported physical consequences (e.g. weight gain, sedentary lifestyle) associated with modification of activity level following FMD diagnosis.
Contact information is provided by the study sponsor or research team.
Vanderbilt University Medical Center
Other
National Survey of Physical Activity Restrictions and Quality of Life Among Patients With Fibromuscular Dysplasia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07526766
Arterial Occlusive Diseases, Cardiovascular Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT01967511
Arterial Occlusive Diseases, Cardiovascular Diseases
New York, United States
View Trial DetailsNCT04906356
Arterial Occlusive Diseases, Cardiovascular Diseases
Vancouver, British Columbia, Canada
View Trial DetailsNCT06955663
Behavior, Coronary Artery Dissection, Spontaneous
Leicester, Leicestershire, United Kingdom
View Trial Details